Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: A structure-function relationship

Cell Proliferation

Volumn 32, Issue 2-3, 1999, Pages 85-99

  Syrokou, A ^a   Tzanakakis, G ^b   Tsegenidis, T ^a   Hjerpe, A ^b   Karamanos, N K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARIN; IDURONIC ACID; KERATAN SULFATE; TRITIUM;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; RADIOASSAY; STRUCTURE ACTIVITY RELATION; SULFATION;

TRITIUM;

EID: 0032855574     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1999.32230085.x     Document Type: Article

References (42)

1. ADAMS JC, WATT F. (1993) Regulation of development and differentiation by the extracellular matrix. Development 117, 1183.
2. ARVANITI A, KARAMANOS NK, DIMITRACOPOULOS G, ANASTASSIOU ED. (1994) Isolation and characterisation of a novel 20-kDa sulfated polysaccharide from the extracellular slime layer of Staphylococcus epidermidis. Arch. Biochem. Biophys. 308, 432.
3. ASPLUND T, HELDIN P. (1994) Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 54, 4516.
4. BENITZ WE, LESSLER DS, COULSON JD, BERNFIELD M. (1986) Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor. J. Cell. Physiol. 127, 1.
5. CASTELLOT JJ, ADDONIZIO ML, ROSENBERG RD, KARNOVSKY MJ. (1981) Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J. Cell. Biol. 90, 372.
6. CASTELLOT JJ, HOOVER RL, HARPER PA, KARNOVSKY MJ. (1985b) Heparin and glomerular epithelial cell-secreted heparin like species inhibit mesanglial cell proliferation. Am. J. Path. 120, 427.
7. CASTELLOT JJ, WONK K, HERMAN B, HOOVER RL, ALBERTINI DF, WRIGHT TC. (1985a) Binding and internalisation of heparin by vascular smooth muscle cells. J. Cell. Physiol. 124, 13.
8. DAVID G. (1993) The integral membrane heparan sulphate proteoglycans. FASEB J. 7, 1023.
9. ENGFELDT B, HJERPE A, MENGARELLI S, REINHOLT FP, WIKSTROM B. (1982) Morphological and biochemical analysis of biopsy specimens in disorders of skeletal development. Acta Paediat. Scand. 71, 353.
10. FRITZE LM, REILLY CF, ROSENBERG RD. (1985) An antiproliferative heparan sulphate species produced by postconfluent smooth muscle cells. J. Cell Biol. 100, 1041.
11. HATA R, NAGAI T. (1972) A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal. Biochem. 45, 462.
12. HELDIN C-H, WESTERMARK B. (1989) Growth factors as transforming proteins. Eur. J. Biochem. 184, 487.
13. JACKSON RL, BUSH SJ, CARDIN AL. (1991) Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71, 481.
14. KARAMANOS NK, AXELSSON S, VANKY P, TZANAKAKIS GN, HJERPE A. (1995) Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteolycans. J. Chromatogr. A. 696, 295.
15. KARAMANOS NK, HJERPE A. (1996) In: Balduini C, Cherubino P, De Luca G, eds. Advances in Biomedical Studies. Biology and Physiopathology of the Extracellular Matrix, Vol. II. Pavia, Italy: La Goliardica Pavese, 71.
16. KARAMANOS NK, HJERPE A. (1997) High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma J. Chromatogr. B. 697, 277.
17. KARAMANOS NK, HJERPE A, TSEGENIDIS T, ENGFELDT B, ANTONOPOULOS CA. (1988) Determination of iduronic acid and glucuronic acid in glycosaminoglycans after stoichiometric reduction and depolymerization using high-performance liquid chromatography and ultraviolet detection. Anal. Biochem. 172, 410.
18. KARAMANOS NK, SYROKOU A, VANKY P, NURMINEN M, HJERPE A. (1994) Determination of 24 variously sulfated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal. Biochem. 221, 189.
19. KARAMANOS NK, VANKY P, TZANAKAKIS GN, HJERPE A. (1996a) High-performance capillary electrophoresis method to characterise heparin and heparan sulphate disaccharides, Electrophoresis 17, 391.
20. KARAMANOS NK, VANKY P, TZANAKAKIS G, TSEGENIDIS T, HJERPE A. (1997) Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate J. Chromatogr. A. 765, 169.
21. KJELLEN L, LINDHAL U. (1991) Structure and functions of proteoglycans. Annu. Rev. Biochem. 60, 443.
22. KLOMINEK J, ROBERT KH, HJERPE A, WICKSTROM B, GAHRTON G. (1989) Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 49, 6118.
23. KRAEMER PM. (1971) Heparan sulphates of cultured cells. I. Membrane-associated and cell-sap species in Chinese hamster cells. Biochemistry 10, 1437.
24. LAURENT TC, LAURENT UB, FRASER JR. (1996) Serum hyaluronan as a disease marker. Ann. Med. 28, 241.
25. NURMINEN M, DEJEMK G, MATRENSSO G, HJERPE A. (1994) Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin. Chem. 40, 777.
26. PETITOU M, LORMEAU JC, CHOAY L, RECHERCHE S. (1991) Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. Nature 350, 30.
27. SAKSELA O, MOSCATTELLI D, SOMMER A, RIFKIN DB. (1988) Endothelial cell-derived heparan sulphate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743.
28. SCOTT JE. (1994) On the polylactose nature of chondroitin and keratan sulphates. Biochem. J. 298, 221.
29. SHIVELY JE, CONRAD HE. (1976) Formation of anhydro-sugars in the chemical depolymerization of heparin, Biochemistry 15, 3932.
30. TSUJI A, KINOSHITA T, HOSHINO M. (1969) Analytical chemical studies on amino sugars. II. Determination of hexosamines using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Chem. Pharm. Bull. 17, 1505.
31. TZANAKAKIS GN, HJERPE A, KARAMANOS NK. (1997) Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79, 323.
32. TZANAKAKIS GN, KARAMANOS NK, HJERPE A. (1995) Effects of glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp. Cell Res. 220, 130.
33. TZANAKAKIS GN, KARAMANOS NK, KLOMINEK J, HJERPE A. (1995a) Glycosaminoglycans from human malignant mesothelioma cell lines: determination, distribution and effect of platelet-derived growth factor on their synthesis. Biochem. Cell Biol. 73, 59.
34. TZANAKAKIS GN, KARAMANOS NK, SYROKOU A, HJERPE A. (1996) Effect of insulin and epidermal growth factors on the synthesis of glycosaminoglycans/proteoglycans in cultured human malignant mesothelioma cells of different phenotypic morphology, APMIS 104, 718.
35. VOLPI N, BOLOGNANI L, CONTE A, PETRINI M. (1993) Effects of chondroitin sulphates with different structures on leukaemia cells: U-937 cell proliferation and differentiation. Leukaemia Res. 17, 789.
36. VOLPI N, PETRINI M, CONTE A et al. (1994) Effects of glycosaminoglycans on U-937 leukaemia cell proliferation and differentiation: Struction-function relationship. Exp. Cell Res. 215, 119.
37. WESTERGREN-THORSSON G, PERSSON S, ISAKSSON A, ONNERVIK PO, MALMSTROM A, FRANSSON LA. (1993) L-iduronate-rich glycosaminglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp. Cell Res. 206, 93.
38. WIGHT TN, KINSELLA MG, QWANSRNSTOM EE. (1992) The role of PGs in cell adhesion, migration and proliferation. Cur. Opin. Cell Biol. 4, 793.
39. WRIGHT TC, CASTELLOT JJ, PETITOU M, LORMEAU J-C, CHOAY J, KARNOVSKY MJ. (1989b) Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge. J. Biol. Chem. 264, 1534.
40. WRIGHT TC, CASTELOT JJ, DIAMOND JR, KARNOVSKY MJ. (1989a). In: Lane DA, Lindahl U, eds. Heparin. Regulation of Cellular Proliferation by Heparin and Heparan Sulphate. London/Melbourne/Auckland: Arlond, 295316.
41. WRIGHT TC, KARNOVSKY MJ. (1987) Metabolic effects of heparin on rat cervical epithelial cells. J. Cell. Physiol. 132, 255.
42. YAYON A, KLAGSBURN M, ESKO JD, LEDER P, ORNITZ DM. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its hgh affinity receptors. Cell 64, 841.